Quest Diagnostics
DGX
#1086
Rank
A$27.02 B
Marketcap
$242.09
Share price
2.03%
Change (1 day)
15.94%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2024 (TTM): A$1.65 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are A$9.53 Billion. In 2023 the company made an earning of A$1.71 Billion a decrease over its 2022 earnings that were of A$1.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$1.65 B-3.7%
2023 A$1.71 B-8.5%
2022 A$1.87 B-52.48%
2021 A$3.94 B37.95%
2020 A$2.86 B75.09%
2019 A$1.63 B16.2%
2018 A$1.40 B-10.1%
2017 A$1.56 B-5.16%
2016 A$1.64 B-1.54%
2015 A$1.67 B31%
2014 A$1.27 B-37.52%
2013 A$2.04 B26.93%
2012 A$1.61 B24.01%
2011 A$1.30 B-27.7%
2010 A$1.79 B-3.55%
2009 A$1.86 B19.59%
2008 A$1.55 B12.54%
2007 A$1.38 B-11.7%
2006 A$1.56 B13.49%
2005 A$1.38 B9.02%
2004 A$1.26 B13.19%
2003 A$1.12 B36.03%
2002 A$0.82 B63.07%
2001 A$0.50 B65.49%
2000 A$0.30 B1297.84%
1999 A$21.84 M-73.37%
1998 A$82.02 M-384.21%
1997 -A$28.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$1.24 B-26.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$5.25 Million-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion-106.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$14.92 Million-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$63.31 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.21 B-87.04%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands